{
    "id": 71,
    "premise": "none",
    "hypothesis": "PKB/Akt binds to the docking site on PIK3\u00a0at the plasma membrane leading to a partial PKB/Akt activation",
    "label": "entailment",
    "explanation": "The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
    "results": {
        "semantic validity": false,
        "premise": null,
        "hypothesis": "PKB/Akt binds to the docking site on PIK3\u00a0at the plasma membrane leading to a partial PKB/Akt activation",
        "history explanation": [
            "0 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "1 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "2 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "3 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "4 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "5 iteration: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT.\nPKB/Akt binds to PIP3\u00a0at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "6 iteration: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT.\nPKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "7 iteration: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT.\nPKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "8 iteration: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT.\nPKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation.",
            "9 iteration: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT.\nPKB/Akt binds to the docking site on PI3K at the plasma membrane, which directly leads to partial PKB/Akt activation by allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop.\u201d",
            "10 iteration: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT.\nPKB/Akt binds to the docking site on PI3K at the plasma membrane, which directly leads to partial PKB/Akt activation by allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop.\u201d\nThe phosphorylation of T308 by PDK1 is necessary for the partial activation of PKB/Akt."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: False",
            "4 iteration: False",
            "5 iteration: False",
            "6 iteration: False",
            "7 iteration: False",
            "8 iteration: False",
            "9 iteration: False",
            "10 iteration: False"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 8.45557427406311, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e1 :: entity \\\\<Rightarrow> bool\\nOperand:   y :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_71_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Recruit :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  DockingSite :: \"event \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  T308 :: \"entity \u21d2 bool\"\\n  ActivationLoop :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n  Lead :: \"event \u21d2 event \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Recruit e1 \u2227 Agent e1 x \u2227 Patient e1 w \u2227 At w v \u2227 DockingSite e2 \u2227 Provide e3 \u2227 Agent e3 x \u2227 Patient e3 w \u2227 Patient e3 v \u2227 For e2 u \u2227 For e2 t\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v e1 e2 e3 e4 e5. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 w \u2227 T308 u \u2227 ActivationLoop v \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Allow e2 \u2227 Access e3 \u2227 Phosphorylate e4 \u2227 Agent e3 w \u2227 Agent e4 w \u2227 Patient e4 u \u2227 In u v \u2227 Activation e5 \u2227 Partial e5 \u2227 Lead e1 e5\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 Lead e1 e2\"\\nproof -\\n  (* From the known information, we have PKB_Akt x, DockingSite y, PI3K z, and PlasmaMembrane w. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  \\n  (* Explanation 2 provides that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* We have a logical relation Implies(D, F), which states that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n  (* We can use this to infer that if PKB/Akt binds to the docking site on PI3K at the plasma membrane, it will also lead to partial PKB/Akt activation. *)\\n  \\n  (* We need to establish the binding event and its consequences. *)\\n  obtain e1 e2 where \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 Lead e1 e2\" <ATP>\\n  \\n  (* Now, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_71_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"event \u21d2 entity \u21d2 bool\"\\n  At :: \"event \u21d2 entity \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 string \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 entity \u21d2 bool\"\\n  Partial :: \"entity \u21d2 bool\"\\n  Activation :: \"entity \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3 e4. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Provide e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Agent e2 w \u2227 To e2 w \u2227 At e2 v \u2227 DockingSite e3 \u2227 Patient e1 e3 \u2227 For e4 u \u2227 For e4 t\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"(\u2203x y z u v w e1 e2 e3 e4. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 u \u2227 T308 v \u2227 Activation w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Allow e2 \u2227 Agent e2 x \u2227 Access e3 \u2227 Agent e3 u \u2227 Phosphorylate e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 In v \\'activation loop\\' \u2227 LeadTo e1 w \u2227 Partial w)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 1 provides that the conversion of PIP2 to PIP3 provides a docking site for PDK1 and AKT. *)\\n  (* Explanation 2 states that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, leading to partial activation. *)\\n  (* From the logical relation Implies(D, F), we know that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial activation. *)\\n  (* Since we have PKB_Akt x and DockingSite y, we can infer that PKB/Akt binds to the docking site on PI3K. *)\\n  have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w\" <ATP>\\n  (* From the derived implication Implies(D, F), we can conclude that this binding leads to partial activation. *)\\n  then have \"Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\n'}",
            "2 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 10.675260066986084, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e1 :: entity \\\\<Rightarrow> bool\\nOperand:   y :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_71_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  DockingSite :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Result :: \"event \u21d2 bool \u21d2 bool\"\\n  PartialActivation :: \"entity \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Provide e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Patient e2 w \u2227 To w v \u2227 Provide e3 \u2227 Agent e3 x \u2227 DockingSite e3 \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z u v w e1 e2 e3 e4 e5. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 u \u2227 T308 v \u2227 ActivationLoop w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Allow e2 \u2227 Agent e2 x \u2227 Access e3 \u2227 Agent e3 u \u2227 Phosphorylate e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 In v w \u2227 Lead e5 \u2227 Agent e5 x \u2227 Result e5 (PartialActivation x)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Lead e2 \u2227 Agent e2 e1 \u2227 Result e2 (PartialActivation x)\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides a logical relation Implies(D, F), which implies PKB/Akt binds to PIP3 at the plasma membrane leads to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* Since we have DockingSite y and PI3K z, we can infer that PKB/Akt binds to the docking site on PI3K. *)\\n  have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w\" <ATP>\\n  (* From the derived implication Implies(D, F), we can infer that binding leads to partial activation. *)\\n  then have \"Lead e2 \u2227 Agent e2 e1 \u2227 Result e2 (PartialActivation x)\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\n'}",
            "3 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 10.455702543258667, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e1 :: entity \\\\<Rightarrow> bool\\nOperand:   y :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_71_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  DockingSite :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  T308 :: \"entity \u21d2 bool\"\\n  ActivationLoop :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 event \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Provide e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Patient e2 w \u2227 To w v \u2227 Provide e3 \u2227 DockingSite e3 \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v e1 e2 e3 e4 e5. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 w \u2227 T308 u \u2227 ActivationLoop v \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Allow e2 \u2227 Access e3 \u2227 Agent e3 w \u2227 Phosphorylate e4 \u2227 Agent e4 w \u2227 Patient e4 u \u2227 In u v \u2227 Activation e5 \u2227 Partial e5 \u2227 LeadTo e1 e5\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\"\\nproof -\\n  (* From the known information, we have PKB_Akt x, DockingSite y, PIK3 z, and PlasmaMembrane w. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides the relation that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* We have a derived implication: Implies(D, F), which states that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PIK3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* Since DockingSite y and PIK3 z are given, we can infer that PKB/Akt binds to the docking site on PIK3. *)\\n  have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w\" <ATP>\\n  (* Using the derived implication Implies(D, F), we can infer partial PKB/Akt activation. *)\\n  then have \"Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\n'}",
            "4 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 6.330028533935547, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Patient e1 :: entity \\\\<Rightarrow> bool\\nOperand:   y :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_71_4\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Convert :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Mediates :: \"event \u21d2 bool\"\\n  DockingSite :: \"event \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  T308 :: \"entity \u21d2 bool\"\\n  ActivationLoop :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 event \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Convert e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 To y z \u2227 Recruitment e2 \u2227 Mediates e2 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 To w v \u2227 DockingSite e3 \u2227 Provide e3 \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v e1 e2 e3 e4. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 w \u2227 T308 u \u2227 ActivationLoop v \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Access e2 \u2227 Agent e2 w \u2227 Phosphorylate e3 \u2227 Agent e3 w \u2227 Patient e3 u \u2227 In u v \u2227 Activation e4 \u2227 Partial e4 \u2227 LeadTo e3 e4\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\"\\nproof -\\n  (* From the known information, we have PKB_Akt x, DockingSite y, PIK3 z, and PlasmaMembrane w. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 and the logical relation Implies(D, F) suggest that PKB/Akt binds to PIP3 at the plasma membrane leads to partial PKB/Akt activation. *)\\n  (* We need to show that this binding is related to the docking site on PIK3 at the plasma membrane. *)\\n  (* Assume the existence of events e1 and e2 for the binding and activation process. *)\\n  then obtain e1 e2 where \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  (* This satisfies the hypothesis that PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to partial PKB/Akt activation. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\n'}",
            "5 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n(* We have a derived implication: Implies(D, F), which states that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n(* Since we have PKB_Akt x and PlasmaMembrane z, we can infer that PKB/Akt binds to the docking site on PIK3 at the plasma membrane, leading to partial activation. *)\\nthen have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 LeadTo e2 \u2227 PartialActivation e2 \u2227 Agent e2 x\" sledgehammer', 'solving time': 103.12207794189453, 'proof tactics': [], 'code': 'theory clinical_71_5\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  Mediate :: \"event \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  For :: \"entity \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  T308 :: \"entity \u21d2 bool\"\\n  ActivationLoop :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 bool\"\\n  PartialActivation :: \"event \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 provides mediates recruitment of PI3K to the plasma membrane and provides a docking site for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane w \u2227 PDK1 y \u2227 AKT z \u2227 Provide e1 \u2227 Mediate e2 \u2227 Recruitment e3 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 Agent e2 x \u2227 Patient e2 z \u2227 Agent e3 w \u2227 Patient e3 w \u2227 DockingSite y \u2227 For y z\"\\n\\n(* Explanation 2: PKB/Akt binds to PIP3 at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w e1 e2 e3 e4. PKB_Akt x \u2227 PIP3 y \u2227 PlasmaMembrane z \u2227 PDK1 w \u2227 T308 y \u2227 ActivationLoop z \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 At y z \u2227 Allow e2 \u2227 Access e3 \u2227 Phosphorylate e4 \u2227 Agent e2 x \u2227 Patient e2 w \u2227 Agent e3 w \u2227 Patient e3 y \u2227 Agent e4 w \u2227 Patient e4 y \u2227 In y z \u2227 LeadTo e4 \u2227 PartialActivation e4 \u2227 Agent e4 x\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane z\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane z \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 LeadTo e2 \u2227 PartialActivation e2 \u2227 Agent e2 x\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PIK3, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PIK3 z \u2227 PlasmaMembrane z\" <ATP>\\n  (* Explanation 2 provides that PKB/Akt binds to PIP3 at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* We have a derived implication: Implies(D, F), which states that if PKB/Akt binds to PIP3 at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n  (* Since we have PKB_Akt x and PlasmaMembrane z, we can infer that PKB/Akt binds to the docking site on PIK3 at the plasma membrane, leading to partial activation. *)\\n  then have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 LeadTo e2 \u2227 PartialActivation e2 \u2227 Agent e2 x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to PIP3 at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(D, F)\\nImplies(PKB/Akt binds to PIP3 at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to PIP3 at the plasma membrane))\\n--------\\n'}",
            "6 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_71_6\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Mediate :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"event \u21d2 entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  DockingSite :: \"event \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"event \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 string \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Mediate e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Patient e2 w \u2227 To e2 v \u2227 Provide e3 \u2227 Agent e3 x \u2227 DockingSite e3 \u2227 On e3 w \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v e1 e2 e3 e4 e5. (PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 PDK1 u \u2227 T308 v \u2227 Activation e5 \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Allow e1 e2 \u2227 Access e2 \u2227 Agent e2 u \u2227 Phosphorylate e3 \u2227 Agent e3 u \u2227 Patient e3 v \u2227 In v \\'activation loop\\' \u2227 LeadTo e3 e4 \u2227 Partial e4 \u2227 Activation e4)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 LeadTo e1 e2 \u2227 Activation e2 \u2227 Partial e2\"\\nproof -\\n  (* From the premise, we have known information about PKB/Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides the logical relation Implies(D, F), which states that if PKB/Akt binds to the docking site on PI3K at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane. *)\\n  (* Explanation 2 also provides the necessary conditions for binding and activation. *)\\n  then have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w\" <ATP>\\n  (* From the logical relation Implies(D, F), we can infer that this binding leads to partial activation. *)\\n  then have \"LeadTo e1 e2 \u2227 Activation e2 \u2227 Partial e2\" <ATP>\\n  (* Combining all the information, we can conclude the hypothesis. *)\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site on PI3K for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to the docking site on PI3K at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to the docking site on PI3K at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site on PI3K for PDK1 and AKT)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site on PI3K for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\n'}",
            "7 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 0, 'proof tactics': [], 'code': 'theory clinical_71_7\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Mediates :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  Provides :: \"event \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n  For :: \"entity \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 string \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 event \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Mediates e1 \u2227 Agent e1 x \u2227 Patient e1 w \u2227 To w v \u2227 Provides e2 \u2227 Agent e2 x \u2227 DockingSite e3 \u2227 On e3 w \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"(\u2203x y z w u v e1 e2 e3 e4 e5. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 PDK1 u \u2227 T308 v \u2227 Activation e5 \u2227 Partial e5 \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Allow e2 \u2227 Agent e2 e1 \u2227 Access e3 \u2227 Agent e3 u \u2227 Phosphorylate e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 In v \\'activation loop\\' \u2227 LeadTo e2 e5)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides the logical relation Implies(D, F), which states that if PKB/Akt binds to the docking site on PI3K at the plasma membrane, it leads to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, which is part of the hypothesis. *)\\n  (* Explanation 2 also provides the necessary conditions for binding and activation. *)\\n  from explanation_2 have \"\u2203e1 e2. Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site on PI3K for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to the docking site on PI3K at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to the docking site on PI3K at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site on PI3K for PDK1 and AKT)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site on PI3K for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\n'}",
            "8 iteration: {'syntactic validity': True, 'error code': '\"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" sledgehammer', 'solving time': 103.4556314945221, 'proof tactics': [], 'code': 'theory clinical_71_8\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Mediate :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n  For :: \"entity \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  LeadTo :: \"event \u21d2 event \u21d2 bool\"\\n  Activation :: \"event \u21d2 bool\"\\n  Partial :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3 s. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Mediate e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Patient e2 w \u2227 To w v \u2227 Provide e3 \u2227 Agent e3 x \u2227 DockingSite s \u2227 On s w \u2227 For s u \u2227 For s t\"\\n\\n(* Explanation 2: PKB/Akt binds to the docking site on PI3K at the plasma membrane, allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop,\u201d leading to partial PKB/Akt activation. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v l e1 e2 e3 e4 e5. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 PDK1 u \u2227 T308 v \u2227 Activation e5 \u2227 Partial e5 \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Allow e2 \u2227 Agent e2 u \u2227 Access e3 \u2227 Agent e3 u \u2227 Phosphorylate e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 In v l \u2227 LeadTo e2 e5\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PIK3 at the plasma membrane leading to a partial PKB/Akt activation. *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides a logical relation: Implies(D, F), which means PKB/Akt binds to the docking site on PI3K at the plasma membrane leads to partial PKB/Akt activation. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane. *)\\n  (* From explanation_2, we have the existence of such a binding event and its consequences. *)\\n  from explanation_2 obtain e1 e2 where\\n    \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  (* Combine the known information and the obtained binding event to conclude the hypothesis. *)\\n  then have \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Activation e2 \u2227 Partial e2 \u2227 LeadTo e1 e2\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site on PI3K for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to the docking site on PI3K at the plasma membrane (from Explanatory Sentence 2)\\nE: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nF: partial PKB/Akt activation (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(E, F)\\nImplies(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d, partial PKB/Akt activation)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to the docking site on PI3K at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site on PI3K for PDK1 and AKT)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site on PI3K for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\n'}",
            "9 iteration: {'syntactic validity': True, 'error code': '(* Explanation 2 provides a logical relation: Implies(D, And(E, F)), which means PKB/Akt binds to the docking site on PI3K at the plasma membrane implies partial PKB/Akt activation and PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d. *)\\n(* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, which is part of the hypothesis. *)\\n(* From explanation_2, we can infer the binding event and its consequences. *)\\nthen have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On e1 z \u2227 At e1 w \u2227 Lead e2 \u2227 Agent e2 x \u2227 Patient e2 x \u2227 PartialActivation x\" sledgehammer', 'solving time': 103.25622844696045, 'proof tactics': [], 'code': 'theory clinical_71_9\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Mediate :: \"event \u21d2 bool\"\\n  Recruitment :: \"event \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  On :: \"event \u21d2 entity \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Directly :: \"event \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  ActivationLoop :: \"entity \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  At :: \"event \u21d2 entity \u21d2 bool\"\\n  PartialActivation :: \"entity \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Mediate e1 \u2227 Agent e1 x \u2227 Recruitment e2 \u2227 Agent e2 w \u2227 Patient e2 v \u2227 Provide e3 \u2227 Agent e3 x \u2227 DockingSite w \u2227 On e3 w \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to the docking site on PI3K at the plasma membrane, which directly leads to partial PKB/Akt activation by allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v t e1 e2 e3 e4. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 PDK1 u \u2227 T308 v \u2227 ActivationLoop t \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On e1 z \u2227 At e1 w \u2227 Lead e2 \u2227 Agent e2 x \u2227 Patient e2 x \u2227 Directly e2 \u2227 Allow e3 \u2227 Agent e3 x \u2227 Patient e3 u \u2227 Access e4 \u2227 Phosphorylate e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 In v t\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On e1 z \u2227 At e1 w \u2227 Lead e2 \u2227 Agent e2 x \u2227 Patient e2 x \u2227 PartialActivation x\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides a logical relation: Implies(D, And(E, F)), which means PKB/Akt binds to the docking site on PI3K at the plasma membrane implies partial PKB/Akt activation and PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d. *)\\n  (* We need to show that PKB/Akt binds to the docking site on PI3K at the plasma membrane, which is part of the hypothesis. *)\\n  (* From explanation_2, we can infer the binding event and its consequences. *)\\n  then have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On e1 z \u2227 At e1 w \u2227 Lead e2 \u2227 Agent e2 x \u2227 Patient e2 x \u2227 PartialActivation x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site on PI3K for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to the docking site on PI3K at the plasma membrane (from Explanatory Sentence 2)\\nE: partial PKB/Akt activation (from Explanatory Sentence 2)\\nF: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nImplies(A, And(B, C))\\nImplies(conversion of PIP2 to PIP3, B & C)\\n--------\\nImplies(D, And(E, F))\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, E & F)\\n--------\\n\\nDerived Implications:\\nImplies(Not(F), Not(D))\\nImplies(Not(PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d), Not(PKB/Akt binds to the docking site on PI3K at the plasma membrane))\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site on PI3K for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(Not(E), Not(D))\\nImplies(Not(partial PKB/Akt activation), Not(PKB/Akt binds to the docking site on PI3K at the plasma membrane))\\n--------\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(Not(B), Not(A))\\nImplies(Not(recruitment of PI3K to the plasma membrane), Not(conversion of PIP2 to PIP3))\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(provides a docking site on PI3K for PDK1 and AKT), Not(conversion of PIP2 to PIP3))\\n--------\\n'}",
            "10 iteration: {'syntactic validity': False, 'error code': '', 'solving time': 9.94052243232727, 'proof tactics': ['Type unification failed: Clash of types \"event\" and \"entity\"\\n\\nType error in application: incompatible operand type\\n\\nOperator:  Agent e2 :: entity \\\\<Rightarrow> bool\\nOperand:   e1 :: event\\n', 'No proof state', 'Bad context for command \"oops\"\\\\<^here> -- using reset state'], 'code': 'theory clinical_71_10\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Conversion :: \"entity \u21d2 bool\"\\n  PIP2 :: \"entity \u21d2 bool\"\\n  PIP3 :: \"entity \u21d2 bool\"\\n  PI3K :: \"entity \u21d2 bool\"\\n  PlasmaMembrane :: \"entity \u21d2 bool\"\\n  PDK1 :: \"entity \u21d2 bool\"\\n  AKT :: \"entity \u21d2 bool\"\\n  Mediate :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  To :: \"entity \u21d2 entity \u21d2 bool\"\\n  Provide :: \"event \u21d2 bool\"\\n  DockingSite :: \"entity \u21d2 bool\"\\n  On :: \"entity \u21d2 entity \u21d2 bool\"\\n  For :: \"entity \u21d2 entity \u21d2 bool\"\\n  PKB_Akt :: \"entity \u21d2 bool\"\\n  Bind :: \"event \u21d2 bool\"\\n  At :: \"entity \u21d2 entity \u21d2 bool\"\\n  Lead :: \"event \u21d2 bool\"\\n  Directly :: \"event \u21d2 bool\"\\n  PartialActivation :: \"entity \u21d2 bool\"\\n  Allow :: \"event \u21d2 bool\"\\n  Access :: \"event \u21d2 bool\"\\n  Phosphorylate :: \"event \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  Phosphorylation :: \"event \u21d2 bool\"\\n  NecessaryFor :: \"event \u21d2 bool \u21d2 bool\"\\n\\n(* Explanation 1: The conversion of PIP2 to PIP3 mediates the recruitment of PI3K to the plasma membrane and provides a docking site on PI3K for PDK1 and AKT. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z w v u t e1 e2 e3. Conversion x \u2227 PIP2 y \u2227 PIP3 z \u2227 PI3K w \u2227 PlasmaMembrane v \u2227 PDK1 u \u2227 AKT t \u2227 Mediate e1 \u2227 Agent e1 x \u2227 Patient e1 w \u2227 To w v \u2227 Provide e2 \u2227 Agent e2 x \u2227 DockingSite e3 \u2227 On e3 w \u2227 For e3 u \u2227 For e3 t\"\\n\\n(* Explanation 2: PKB/Akt binds to the docking site on PI3K at the plasma membrane, which directly leads to partial PKB/Akt activation by allowing PDK1 to access and phosphorylate T308 in the \u201cactivation loop. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y z w u v t e1 e2 e3 e4 e5. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 PDK1 u \u2227 T308 v \u2227 ActivationLoop t \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Lead e2 \u2227 Agent e2 x \u2227 Patient e2 x \u2227 Directly e2 \u2227 PartialActivation x \u2227 Allow e3 \u2227 Agent e3 x \u2227 Patient e3 u \u2227 Access e4 \u2227 Agent e4 u \u2227 Patient e4 v \u2227 Phosphorylate e5 \u2227 Agent e5 u \u2227 Patient e5 v \u2227 In v t\"\\n\\n(* Explanation 3: The phosphorylation of T308 by PDK1 is necessary for the partial activation of PKB/Akt. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e. Phosphorylation e \u2227 T308 y \u2227 PDK1 z \u2227 Agent e z \u2227 Patient e y \u27f6 (NecessaryFor e (PartialActivation x))\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\"\\n  (* Hypothesis: PKB/Akt binds to the docking site on PI3K at the plasma membrane leading to a partial PKB/Akt activation *)\\n  shows \"\u2203x y z e1 e2. PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w \u2227 Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Lead e2 \u2227 Agent e2 e1 \u2227 Patient e2 x \u2227 PartialActivation x\"\\nproof -\\n  (* From the premise, we have known information about PKB_Akt, DockingSite, PI3K, and PlasmaMembrane. *)\\n  from asm have \"PKB_Akt x \u2227 DockingSite y \u2227 PI3K z \u2227 PlasmaMembrane w\" <ATP>\\n  (* Explanation 2 provides the relation that PKB/Akt binds to the docking site on PI3K at the plasma membrane, leading to partial PKB/Akt activation. *)\\n  (* There is a logical relation Implies(D, E), Implies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation) *)\\n  (* We can use this to infer the binding and partial activation. *)\\n  then have \"Bind e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 On y z \u2227 At y w \u2227 Lead e2 \u2227 Agent e2 e1 \u2227 Patient e2 x \u2227 PartialActivation x\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: conversion of PIP2 to PIP3 (from Explanatory Sentence 1)\\nB: recruitment of PI3K to the plasma membrane (from Explanatory Sentence 1)\\nC: provides a docking site on PI3K for PDK1 and AKT (from Explanatory Sentence 1)\\nD: PKB/Akt binds to the docking site on PI3K at the plasma membrane (from Explanatory Sentence 2)\\nE: partial PKB/Akt activation (from Explanatory Sentence 2)\\nF: PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d (from Explanatory Sentence 2)\\nG: phosphorylation of T308 by PDK1 (from Explanatory Sentence 4)\\nH: necessary for the partial activation of PKB/Akt (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(A, B)\\nImplies(conversion of PIP2 to PIP3, recruitment of PI3K to the plasma membrane)\\n--------\\nImplies(A, C)\\nImplies(conversion of PIP2 to PIP3, provides a docking site on PI3K for PDK1 and AKT)\\n--------\\nImplies(D, E)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, partial PKB/Akt activation)\\n--------\\nImplies(D, F)\\nImplies(PKB/Akt binds to the docking site on PI3K at the plasma membrane, PDK1 accesses and phosphorylates T308 in the \u201cactivation loop\u201d)\\n--------\\nImplies(G, H)\\nImplies(phosphorylation of T308 by PDK1, necessary for the partial activation of PKB/Akt)\\n--------\\n\\nDerived Implications:\\n'}"
        ]
    }
}